[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2980365B1 - Nanoemulsions, leur procede de preparation, et leur utilisation comme agent de contraste. - Google Patents

Nanoemulsions, leur procede de preparation, et leur utilisation comme agent de contraste.

Info

Publication number
FR2980365B1
FR2980365B1 FR1158565A FR1158565A FR2980365B1 FR 2980365 B1 FR2980365 B1 FR 2980365B1 FR 1158565 A FR1158565 A FR 1158565A FR 1158565 A FR1158565 A FR 1158565A FR 2980365 B1 FR2980365 B1 FR 2980365B1
Authority
FR
France
Prior art keywords
nanoemulsions
preparation
contrast agent
contrast
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1158565A
Other languages
English (en)
Other versions
FR2980365A1 (fr
Inventor
Caroline Robic
Samy Chadel
Veronique Schmitt
Calderon Fernando Leal
Marc Port
Olivier Lambert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guerbet SA
Original Assignee
Guerbet SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet SA filed Critical Guerbet SA
Priority to FR1158565A priority Critical patent/FR2980365B1/fr
Priority to PCT/EP2012/068984 priority patent/WO2013045504A1/fr
Publication of FR2980365A1 publication Critical patent/FR2980365A1/fr
Application granted granted Critical
Publication of FR2980365B1 publication Critical patent/FR2980365B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1809—Micelles, e.g. phospholipidic or polymeric micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR1158565A 2011-09-26 2011-09-26 Nanoemulsions, leur procede de preparation, et leur utilisation comme agent de contraste. Active FR2980365B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1158565A FR2980365B1 (fr) 2011-09-26 2011-09-26 Nanoemulsions, leur procede de preparation, et leur utilisation comme agent de contraste.
PCT/EP2012/068984 WO2013045504A1 (fr) 2011-09-26 2012-09-26 Nanoemulsions perfluorées, leur procede de preparation, et leur utilisation comme agent de contraste

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1158565A FR2980365B1 (fr) 2011-09-26 2011-09-26 Nanoemulsions, leur procede de preparation, et leur utilisation comme agent de contraste.

Publications (2)

Publication Number Publication Date
FR2980365A1 FR2980365A1 (fr) 2013-03-29
FR2980365B1 true FR2980365B1 (fr) 2016-02-12

Family

ID=46934583

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1158565A Active FR2980365B1 (fr) 2011-09-26 2011-09-26 Nanoemulsions, leur procede de preparation, et leur utilisation comme agent de contraste.

Country Status (2)

Country Link
FR (1) FR2980365B1 (fr)
WO (1) WO2013045504A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11406722B2 (en) 2017-03-16 2022-08-09 The Board Of Regents Of The University Of Texas System Nanodroplets with improved properties
WO2020007822A1 (fr) 2018-07-02 2020-01-09 Conservatoire National Des Arts Et Metiers (Cnam) Nanoparticules de bismuth métallique (0), procédé de fabrication et utilisations de celles-ci
CN114369647B (zh) * 2021-12-31 2024-10-25 深圳麦科田生物医疗技术股份有限公司 一种用于微滴式数字pcr的油包水液滴及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927623A (en) 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
US5077036A (en) 1986-01-14 1991-12-31 Alliance Pharmaceutical Corp. Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
US5171755A (en) 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
US5114703A (en) 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
US5409688A (en) 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US5304325A (en) 1991-11-13 1994-04-19 Hemagen/Pfc Emulsions containing alkyl- or alkylglycerophosphoryl choline surfactants and methods of use
US5403575A (en) 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them
US5958371A (en) 1995-06-08 1999-09-28 Barnes-Jewish Hospital Site specific binding system, nuclear imaging compositions and methods
US5733526A (en) * 1995-12-14 1998-03-31 Alliance Pharmaceutical Corp. Hydrocarbon oil/fluorochemical preparations and methods of use
US6676963B1 (en) 2000-10-27 2004-01-13 Barnes-Jewish Hospital Ligand-targeted emulsions carrying bioactive agents
US7255875B2 (en) 2002-01-24 2007-08-14 Barnes-Jewish Hospital Integrin targeted imaging agents
FR2883562B1 (fr) * 2005-03-24 2009-02-27 Guerbet Sa Chelates lipophiles et leur utilisation en imagerie
WO2007100715A2 (fr) * 2006-02-24 2007-09-07 Washington University Marquage cellulaire avec nanoparticules de perfluorocarbone pour imagerie à résonance magnétique et spectroscopie
WO2007112100A2 (fr) * 2006-03-24 2007-10-04 The University Of Utah Research Foundation Huiles et tensioactifs hautement fluorés et procédés de fabrication et d'utilisation de ceux-ci
KR101005561B1 (ko) * 2008-06-21 2011-01-05 한국생명공학연구원 광학특성 나노입자 및 퍼플루오로카본으로 구성된 나노에멀젼을 이용한 다중모드 조영 방법

Also Published As

Publication number Publication date
FR2980365A1 (fr) 2013-03-29
WO2013045504A1 (fr) 2013-04-04

Similar Documents

Publication Publication Date Title
IL231591A (en) Preserved benzyl indazoles, a process for their preparation and use
EP2767773A4 (fr) Système d'alimentation en eau chaude et de climatisation
EP2694683A4 (fr) ACIDES NUCLÉIQUES GAMMA-PEPTIDIQUES CONTENANT DU MiniPEG, CONFORMATIONNELLEMENT PRÉORGANISÉS
GB201216143D0 (en) .
EP2845499A4 (fr) Machine à fabriquer des tubes de papier, procédé de fabrication de ces derniers et tube de papier fabriqué par ledit procédé de fabrication
HK1212625A1 (zh) 用於炎性疾病的抗- 、抗- 、抗- 、抗- 、抗- 和抗- 試劑
PL2920363T3 (pl) Układ środka papierniczego, sposób wytwarzania układu środka papierniczego oraz jego zastosowanie
HK1197242A1 (en) Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines -56--4h-[13]
GB201203412D0 (en) .
EP2675773A4 (fr) Procédé de préparation de cis-1-chloro-3,3,3-trifluoropropène
HRP20182001T1 (hr) Topljivi medijator
EP2828597B8 (fr) Dispositif pour la condensation de vapeur
HK1207887A1 (en) Assays, methods and apparatus for assessing rna disruption rna
EP2671860A4 (fr) Procédé pour purifier le 2,3,3,3-tétrafluoropropène
EP2909271A4 (fr) Compositions de poly(dihydrocarbylsiloxane) thermoplastique, et fibres, et procédés de fabrication de fibres
IT1397962B1 (it) Processo per la preparazione del nebivololo.
EP2814797A4 (fr) Procédé pour la production de 1,3,3,3-tétrafluoropropène
IT1402974B1 (it) Processo per la preparazione del nebivololo.
EP2808387A4 (fr) Oligonucléotide pour détection du vih, et kit ainsi que procédé de détection du vih
FR2973037B1 (fr) Adhesifs structuraux, procede pour leur preparation, et leur application
EP2796439A4 (fr) Procédé de purification du (e)-1-chloro-3,3,3-trifluoropropène
GB201203063D0 (en) .
IT1399912B1 (it) Processo di preparazione di ritodrina cloridrato.
FR2980365B1 (fr) Nanoemulsions, leur procede de preparation, et leur utilisation comme agent de contraste.
FI20115572A0 (fi) Päätyosa katalysaattoria varten, katalysaattori ja menetelmä katalysaattorin käyttämiseksi

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14